We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$157M
1-Year Est. Return
46.57%
This Fund
S&P 500
This Quarter
Est. Return
+9.19%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
–
AUM
$111M
AUM Growth
–
Cap. Flow
+$109M
Cap. Flow
% of AUM
97.8%
Top 10 Holdings %
Top 10 Hldgs %
35.94%
Holding
105
New
105
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$6.57M |
| 2 |
Data I/O
DAIO
|
+$5.31M |
| 3 |
Amazon
AMZN
|
+$4.95M |
| 4 |
ESIO
Electro Scientific Industries
ESIO
|
+$4.42M |
| 5 |
Microsoft
MSFT
|
+$4.25M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.96% |
| 2 | Healthcare | 12.66% |
| 3 | Energy | 10.8% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
1
Novo Nordisk
NVO
$208B
| $6.93M | 6.24% |
+258,200
| New | +$6.57M |
|
|
2
Data I/O
DAIO
$30.4M
| $5.4M | 4.86% |
+448,340
| New | +$5.31M |
|
|
3
Amazon
AMZN
$3.06T
| $5.25M | 4.73% |
+89,880
| New | +$4.95M |
|
|
ESIO
4
DELISTED
Electro Scientific Industries
ESIO
| $4.72M | 4.25% |
+220,260
| New | +$4.42M |
|
|
5
Microsoft
MSFT
$3.62T
| $4.43M | 3.99% |
+51,815
| New | +$4.25M |
|
6
Kulicke & Soffa
KLIC
$4.72B
| $3.34M | 3% |
+137,100
| New | +$3.27M |
|
7
Axcelis
ACLS
$4.03B
| $2.78M | 2.5% |
+96,805
| New | +$3.05M |
|
8
Alphabet (Google) Class C
GOOG
$4.56T
| $2.5M | 2.25% |
+47,740
| New | +$2.43M |
|
9
Moody's
MCO
$83.7B
| $2.31M | 2.08% |
+15,650
| New | +$2.29M |
|
|
10
Alphabet (Google) Class A
GOOGL
$4.57T
| $2.27M | 2.04% |
+43,040
| New | +$2.22M |
|
11
Fidelity National Financial
FNF
$13.9B
| $2.18M | 1.97% |
+57,890
| New | +$2.11M |
|
12
State Street SPDR S&P 500 ETF Trust
SPY
$806B
| $2.14M | 1.93% |
+8,015
| New | +$2.08M |
|
|
TWOU
13
DELISTED
2U Inc
TWOU
| $2.13M | 1.92% |
+1,100
| New | +$2.07M |
|
14
Chegg
CHGG
$114M
| $1.98M | 1.78% |
+121,125
| New | +$1.85M |
|
15
Kopin
KOPN
$693M
| $1.72M | 1.55% |
+537,905
| New | +$1.85M |
|
|
GCI
16
DELISTED
Gannett Co., Inc
GCI
| $1.62M | 1.46% |
+139,510
| New | +$1.46M |
|
17
Verizon
VZ
$197B
| $1.56M | 1.41% |
+29,537
| New | +$1.45M |
|
|
MESO
18
Mesoblast
MESO
$1.88B
| $1.56M | 1.4% |
+133,400
| New | +$1.51M |
|
19
Thomson Reuters
TRI
$44.4B
| $1.55M | 1.4% |
+30,633
| New | +$1.6M |
|
|
PRCP
20
DELISTED
Perceptron Inc
PRCP
| $1.54M | 1.39% |
+159,043
| New | +$1.43M |
|
|
CEQP
21
DELISTED
Crestwood Equity Partners LP
CEQP
| $1.53M | 1.38% |
+59,378
| New | +$1.45M |
|
22
Navigator Holdings
NVGS
$1.35B
| $1.48M | 1.33% |
+150,325
| New | +$1.56M |
|
|
CYBE
23
DELISTED
Cyberoptics Corp
CYBE
| $1.42M | 1.28% |
+94,600
| New | +$1.38M |
|
|
CRCM
24
DELISTED
CARE.COM, INC.
CRCM
| $1.34M | 1.21% |
+74,435
| New | +$1.3M |
|
|
ARRS
25
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $1.25M | 1.12% |
+48,504
| New | +$1.36M |
|
Similar funds
IWM
EP
AC
SF
LAM
HAM
HEM
CF
Penbrook Management's Q4 2017 Portfolio in Review
Q4 2017 is the first quarter with a 13F filing on record for Penbrook Management, which disclosed 105 positions worth $111M. Its ten largest holdings account for 36% of the portfolio.
Its largest position is Novo Nordisk: 258,200 shares worth $6.93M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, followed by Healthcare and Energy.
- Penbrook Management's largest Q4 2017 buy was Novo Nordisk: 258,200 shares worth $6.93M.
- Penbrook Management's ten largest holdings make up 36% of its $111M portfolio in Q4 2017.
- Penbrook Management disclosed 105 positions in Q4 2017, its first 13F filing on record.
Based on Penbrook Management's 13F filing for Q4 2017, filed 21 Feb 2018.